Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001704336-26-000002

Options or other derivatives

  • President & CEO acquired 436,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cloonan Michael President & CEO 2026-01-02 Grant or award · Non-Qualified Stock Option (right to buy) +436,100 436,100 D
Loading xslF345X05/edgardoc.xml…